Stock Scorecard
Stock Summary for Edwards Lifesciences Corp (EW) - $79.64 as of 4/10/2026 6:07:34 PM EST
Total Score
10 out of 30
Safety Score
58 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for EW
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for EW
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for EW
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for EW
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for EW (58 out of 100)
| Stock Price Rating (Max of 10) | 9 |
| Historical Stock Price Rating (Max of 10) | 9 |
| Stock Price Trend (Max of 10) | 7 |
| Book Value (Max of 10) | 6 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 5 |
| Analyst Strong Buy Ratings (Max of 5) | 5 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 5 |
| Trading Volume (Max of 10) | 10 |
| Price to Earnings (Max of 10) | 2 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for EW
Financial Details for EW
Company Overview |
|
|---|---|
| Ticker | EW |
| Company Name | Edwards Lifesciences Corp |
| Country | USA |
| Description | Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring. |
| Sector Name | HEALTHCARE |
| Industry Name | MEDICAL DEVICES |
| Most Recent Quarter | 12/31/2025 |
| Next Earnings Date | 4/22/2026 |
Stock Price History |
|
| Last Day Price | 79.64 |
| Price 4 Years Ago | 74.61 |
| Last Day Price Updated | 4/10/2026 6:07:34 PM EST |
| Last Day Volume | 5,469,210 |
| Average Daily Volume | 4,613,729 |
| 52-Week High | 87.89 |
| 52-Week Low | 68.63 |
| Last Price to 52 Week Low | 16.04% |
Valuation Measures |
|
| Trailing PE | 43.20 |
| Industry PE | 38.46 |
| Sector PE | 59.23 |
| 5-Year Average PE | 24.40 |
| Free Cash Flow Ratio | 15.62 |
| Industry Free Cash Flow Ratio | 26.23 |
| Sector Free Cash Flow Ratio | 26.91 |
| Current Ratio Most Recent Quarter | 3.72 |
| Total Cash Per Share | 5.10 |
| Book Value Per Share Most Recent Quarter | 17.80 |
| Price to Book Ratio | 4.36 |
| Industry Price to Book Ratio | 4.05 |
| Sector Price to Book Ratio | 17.67 |
| Price to Sales Ratio Twelve Trailing Months | 7.49 |
| Industry Price to Sales Ratio Twelve Trailing Months | 3.99 |
| Sector Price to Sales Ratio Twelve Trailing Months | 21.38 |
| Analyst Buy Ratings | 16 |
| Analyst Strong Buy Ratings | 5 |
Share Statistics |
|
| Total Shares Outstanding | 576,542,000 |
| Market Capitalization | 45,915,804,880 |
| Institutional Ownership | 92.44% |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 2.23% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | -76.60% |
| Annual Earnings Growth | -74.28% |
| Reported EPS 12 Trailing Months | 1.81 |
| Reported EPS Past Year | 0.00 |
| Reported EPS Prior Year | 2.56 |
| Net Income Twelve Trailing Months | 1,070,100,000 |
| Net Income Past Year | 1,073,500,000 |
| Net Income Prior Year | 4,174,600,000 |
| Quarterly Revenue Growth YOY | 13.30% |
| 5-Year Revenue Growth | 6.70% |
| Operating Margin Twelve Trailing Months | 23.70% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 2,938,500,000 |
| Total Cash Past Year | 2,938,500,000 |
| Total Cash Prior Year | 3,045,200,000 |
| Net Cash Position Most Recent Quarter | 2,340,200,000 |
| Net Cash Position Past Year | 2,340,200,000 |
| Long Term Debt Past Year | 598,300,000 |
| Long Term Debt Prior Year | 597,700,000 |
| Total Debt Most Recent Quarter | 598,300,000 |
| Equity to Debt Ratio Past Year | 0.95 |
| Equity to Debt Ratio Most Recent Quarter | 0.95 |
| Total Stockholder Equity Past Year | 10,337,600,000 |
| Total Stockholder Equity Prior Year | 9,998,400,000 |
| Total Stockholder Equity Most Recent Quarter | 10,337,600,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 1,335,000,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 2.32 |
| Free Cash Flow Past Year | 1,335,000,000 |
| Free Cash Flow Prior Year | 289,900,000 |
Options |
|
| Put/Call Ratio | 0.15 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -1.12 |
| MACD Signal | -0.76 |
| 20-Day Bollinger Lower Band | 76.10 |
| 20-Day Bollinger Middle Band | 82.29 |
| 20-Day Bollinger Upper Band | 88.47 |
| Beta | 0.94 |
| RSI | 37.93 |
| 50-Day SMA | 79.86 |
| 150-Day SMA | 77.92 |
| 200-Day SMA | 79.60 |
System |
|
| Modified | 4/15/2026 11:09:27 PM EST |